Wound healing is a complex biological process involving inflammation, new blood vessel formation, and tissue remodeling. Topical metformin is being investigated as a potential medication for wound healing, with early research showing encouraging results compared with controls.Â
In a controlled animal study, wounds treated with 0.1% metformin hydrogel demonstrated significantly greater wound contraction than those receiving placebo hydrogel, with differences observed beginning on day 7 (p < 0.05). Human research involving 30 patients using 0.6% metformin hydrogel also reported complete healing of traumatic wounds within 21 days and cutaneous ulcers within 30 days, representing improvements from baseline wound conditions. This article examines the clinical findings, treatment protocols, evidence limitations, and considerations for patient-specific compounded topical preparations.
What Is Topical Metformin for Wound Healing?
Wound healing involves overlapping stages of inflammation, tissue formation, and remodeling. Poor circulation, infection, and underlying medical conditions can interfere with these processes and contribute to delayed healing.
Researchers are investigating topical metformin for its potential to influence inflammatory activity and tissue repair at the wound site. Unlike oral metformin, which is primarily used for blood glucose management, topical formulations deliver the medication directly to the intended site of action.
Studies have evaluated metformin in hydrogels, lotions, and experimental drug-delivery systems. These formulations differ in concentration, drug release, and contact with wound tissue.
How Does Metformin Work in Wound Healing?
Research suggests that metformin may influence several processes involved in wound repair:
- Inflammation: May modulate inflammatory signaling associated with tissue injury.
- Angiogenesis: May influence pathways involved in forming new blood vessels that supply healing tissue.
- Collagen remodeling: Experimental studies have reported changes in collagen organization and cells associated with scar formation.
- Cellular repair: AMPK activation and autophagy signaling may influence cellular responses involved in tissue regeneration.
A 2025 systematic review by Maghsoodloo et al. examined 26 studies involving topical metformin and reported findings related to inflammatory signaling, blood vessel formation, collagen deposition, and wound closure.
What Does the Clinical Evidence Show?
In a study by Tawfeek et al., researchers investigated topical metformin hydrochloride hydrogel for wound healing through human clinical observations and controlled animal experiments.
The human study followed 30 patients with lower-limb traumatic wounds or cutaneous ulcers, assessing wound healing relative to baseline. The animal study compared metformin-containing hydrogel with a placebo hydrogel to evaluate differences in wound contraction.
What Do These Results Suggest?
The study provides evidence that topical metformin may support wound healing, with findings from both human observations and controlled animal experiments.
In the human study, researchers observed improvements relative to baseline wound conditions, reporting complete healing of traumatic wounds within 21 days and cutaneous ulcers within 30 days. Tissue assessments also showed re-epithelialization, new granulation tissue formation, and restoration of connective-tissue structures.Â
The controlled animal study demonstrated a more direct contrast. By day 7, wounds treated with metformin hydrogel showed 99.34% ± 0.56% wound contraction, whereas researchers reported no improvement in the placebo-treated wounds even after 14 days. This difference was statistically significant (p < 0.05), suggesting a potential contribution from metformin beyond the hydrogel vehicle alone.
Together, these findings support topical metformin as a potential wound-healing therapy.
What Have Laboratory and Animal Studies Found?
Several preclinical studies have explored these potential mechanisms using different topical formulations.
Leng et al. (2022) investigated a metformin-containing hydrogel designed for controlled drug release. Researchers reported anti-inflammatory, antibacterial, and angiogenesis-related findings. Because the preparation contained additional functional materials, its antibacterial activity cannot be attributed to metformin alone.
In a 2024 rat study, Zhang et al. evaluated 6% metformin lotion applied daily for 10 days. Investigators reported AMPK activation, reduced TGF-β1 expression, fewer myofibroblasts, and collagen changes associated with less scar-like tissue.
Tombulturk et al. (2022) also reported changes in inflammatory signaling and tissue-remodeling markers following topical metformin application.
These findings provide a scientific rationale for further investigation, but animal studies cannot establish dosing or clinical outcomes for human wound care.
What Should Prescribers Consider?
For prescribers, relevant considerations include wound type, formulation characteristics, application requirements, and the limitations of available clinical evidence.
Application, Frequency, Storage, and Handling
Published studies have evaluated topical metformin using different concentrations, dosage forms, and application protocols.
- Concentration: The human study evaluated 0.6% metformin hydrochloride hydrogel. This is the primary concentration reported in human wound-healing research.
- Application: The preparation is applied to the intended wound area according to the prescribed instructions and wound-care protocol.
- Frequency: The human study evaluated twice-daily application for up to one month.Â
- Storage: Requirements depend on the formulation and should follow the dispensing pharmacy’s labeled instructions.
- Handling: Keep the preparation securely closed, avoid contaminating the container or applicator, and follow the labeled beyond-use date.
- Follow-up: The treating clinician should monitor wound progression and determine whether changes to the care plan are needed.
The prescriber should determine the application protocol, duration, and follow-up based on the patient’s wound characteristics and clinical needs.
Topical Compounding Through Healing Dose Compounding Pharmacy
Healing Dose Compounding Pharmacy works with prescribers to prepare patient-specific topical medications when compounding is clinically appropriate.
For topical metformin, formulation considerations may include the prescribed concentration, vehicle, application area, and compatibility of ingredients. Our pharmacists can work with prescribers to discuss these requirements and determine whether a particular preparation is available.
Based in Farmington Hills, Michigan, Healing Dose has provided compounded prescription care since 1996 and serves several states. Prescribers can contact the pharmacy to discuss formulation considerations, prescription requirements, and patient-specific availability.
Important Compounding Disclaimer
Topical metformin compounded for wound healing is not FDA-approved for this indication. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality before marketing. Use should be based on the prescriber’s independent clinical judgment, applicable compounding requirements, and the individual patient’s needs.
References
- Leng, T., Wang, Y., Cheng, W., Wang, W., Qu, X., & Lei, B. (2022). Bioactive anti-inflammatory antibacterial metformin-contained hydrogel dressing accelerating wound healing. Biomaterials Advances, 135, Article 212737. Study
- Maghsoodloo, D., Zartab, H., Alipour, M., Rezaei Zadeh Rukerd, M., Mirkamali, H., Parsi-Moud, A., & Firooz, A. (2025). Topical metformin in wound healing: A comprehensive systematic review of therapeutic outcomes. Archives of Dermatological Research, 317, Article 760. Study
- Tawfeek, H. M., Abou-Taleb, D. A. E., Badary, D. M., Ibrahim, M., & Abdellatif, A. A. H. (2020). Pharmaceutical, clinical, and immunohistochemical studies of metformin hydrochloride topical hydrogel for wound healing application. Archives of Dermatological Research, 312, 113–121. Study
- Tombulturk, F. K., Todurga-Seven, Z. G., Huseyinbas, O., Ozyazgan, S., Ulutin, T., & Kanigur-Sultuybek, G. (2022). Topical application of metformin accelerates cutaneous wound healing in streptozotocin-induced diabetic rats. Molecular Biology Reports, 49, 73–83. Study
- Zhang, J., Shimozaki, K., Hattori, S., Pastukh, V., Maloney, D., Hogan, M. V., & Wang, J. H.-C. (2024). Metformin lotion promotes scarless skin tissue formation through AMPK activation, TGF-β1 inhibition, and reduced myofibroblast numbers. PLOS ONE, 19(10), Article e0311147. Study
